ACEKX
Price
$11.95
Change
+$0.03 (+0.25%)
Updated
Aug 21 closing price
Net Assets
13.22B
IFACX
Price
$27.96
Change
+$0.14 (+0.50%)
Updated
Aug 21 closing price
Net Assets
148.23B
Interact to see
Advertisement

ACEKX vs IFACX

ACEKX vs IFACX Comparison Chart in %
View a ticker or compare two or three
VS
ACEKX vs. IFACX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACEKX is a StrongBuy and IFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
IFACX has more cash in the bank: 148B vs. ACEKX (13.2B). IFACX pays higher dividends than ACEKX: IFACX (2.78) vs ACEKX (1.85). ACEKX was incepted earlier than IFACX: ACEKX (16 years) vs IFACX (25 years). IFACX (1.31) is less costly to investors than ACEKX (0.49). ACEKX is a more actively managed with annual turnover of: 136.00 vs. IFACX (65.00). IFACX has a lower initial minimum investment than ACEKX: IFACX (250) vs ACEKX (1000000). ACEKX annual gain was more profitable for investors over the last year : 10.74 vs. IFACX (8.45). IFACX return over 5 years is better than : 23.42 vs. ACEKX (7.68).
ACEKXIFACXACEKX / IFACX
Total Expense Ratio0.481.3137%
Annual Report Gross Expense Ratio0.491.3137%
Fund Existence16 years25 years-
Gain YTD9.93710.11498%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets13.2B148B9%
Annual Yield % from dividends1.852.7867%
Returns for 1 year10.748.45127%
Returns for 3 years28.4839.1273%
Returns for 5 years7.6823.4233%
Returns for 10 years42.3952.3781%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSWYX24.540.28
+1.15%
Hartford Schroders International Stk Y
REQCX44.120.32
+0.73%
Russell Investments Sustainable Equity C
MTCIX84.880.56
+0.66%
MFS Technology I
RYAWX135.340.73
+0.54%
Rydex S&P 500 Pure Growth H
MGNDX59.720.23
+0.39%
Praxis Growth Index A